Candidatas a vacunas contra el coronavirus según fabricante y fase de investigación
(3 de noviembre de 2020)
Fase investigación
Fase
Sinovac
Wuhan Institute of Biological Products/Sinopharm
Beijing Institute of Biological Products/Sinopharm
University of Oxford/AstraZeneca
CanSino Biological Inc./Beijing Institute of Biotechnology
Gamaleya Research Institute
Janssen Pharmaceutical Companies
Novavax
Moderna/NIAID
BioNTech/Fosun Pharma/Pfizer
Anhui Zhifei Longcom Biopharmaceutical/Institute of Microbiology, Chinese Academy of Sciences
Curevac
Institute of Medical Biology, Chinese Academy of Medical Sciences
Research Institute for Biological Safety Problems, Rep of Kazakhstan
Beijing Minhai Biotechnology Co., Ltd.
Inovio Pharmaceuticals/ International Vaccine Institute
Osaka University/ AnGes/ Takara Bio
Cadila Healthcare Limited
Genexine Consortium
Bharat Biotech
Kentucky Bioprocessing, Inc
Sanofi Pasteur/GSK
Israel Institute for Biological Research/Weizmann Inst. of Science
Arcturus/Duke-NUS
SpyBiotech/Serum Institute of India
Symvivo
ImmunityBio, Inc. & NantKwest Inc.
ReiThera/LEUKOCARE/Univercells
CanSino Biological Inc/Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China
Vaxart
Ludwig-Maximilians - University of Munich
Clover Biopharmaceuticals Inc./GSK/Dynavax
Vaxine Pty Ltd/Medytox
University of Queensland/CSL/Seqirus
Medigen Vaccine Biologics Corporation/NIAID/Dynavax
Instituto Finlay de Vacunas, Cuba
FBRI SRC VB VECTOR, Rospotrebnadzor, Koltsovo
West China Hospital, Sichuan University
University Hospital Tuebingen
COVAXX / United Biomedical Inc. Asia
Merck Sharp & Dohme/IAVI
Institute Pasteur/Themis/Univ. of Pittsburg CVR/Merck Sharp & Dohme
Beijing Wantai Biological Pharmacy/ Xiamen University
Imperial College London
People's Liberation Army (PLA) Academy of Military Sciences/Walvax Biotech.
Medicago Inc.
OMS